Cancer Therapy

Study shows patients get more benefit than thought from early cancer treatment

Published in Drug Law Weekly, March 22nd, 2005

People with advanced cancers who try experimental treatments are helped more than previously thought, according to the most comprehensive look at U.S. government-sponsored tests over a decade.

These are patients who haven't benefited from other therapies and have few options left. But testing new treatments on them has been criticized by some who feel the patients are given false hope, since previous reviews showed they only worked in about 4% to 6% of patients.

However, this latest and largest study found that about 11% were helped by experimental treatment, and in some cases as many as 27% were better off.

"The numbers aren't as...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly

Source: Drug Law Weekly (2005-03-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry